hemotherapy


Also found in: Dictionary, Wikipedia.
Related to hemotherapy: homeopathy, chemotherapy, autohemotherapy

hemotherapy

 [he″mo-ther´ah-pe]
the use of blood in treating disease.

he·mo·ther·a·py

, hemotherapeutics (hē'mō-thār'ă-pē, hē'mō-thār-ă-pyū'tiks),
Treatment of disease by the use of blood or blood derivatives, as in transfusion.
Synonym(s): hematherapy

he·mo·ther·a·py

, hemotherapeutics (hē'mō-thār'ă-pē, -thār-ă-pyū'tiks)
Treatment of disease by the use of blood or blood derivatives, as in transfusion.
Synonym(s): haemotherapy, haemotherapeutics.

hemotherapy

the use of blood in treating disease.
Mentioned in ?
References in periodicals archive ?
The medical director may write recommendations to clinicians for future hemotherapy and treatment, perhaps including the use of leukocyte-depleted or antigen-negative red cells, premedication with antipyretics or antihistamines before transfusion, the use of crossmatch-compatible or apheresis platelets instead of random platelet concentrates, or obtaining the patient's tissue type in preparation for supplying HLA-matched components.
Treatment may include surgery, radiation therapy, hemotherapy, bone marrow transplantation.
Contract notice: Announcement of the hospital clinic of barcelona on procurement notice apheresis consumables supply for hemotherapy and hemostasis.
Miquel Lozano, MD, PhD Chief of the Hemotherapy Section of the Department of Hemotherapy and Hemostasis, Hospital Clinic of Barcelona, Barcelona, Spain.
BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced that it has joined the Biomedical Excellence for Safer Transfusion (BEST) Collaborative, an international consortium of leading scientific, clinical, and commercial partners whose mission is to explore collaborative ways to improve transfusion-related services through standardization of analytic techniques, development of new procedures and execution of clinical trials in hemotherapy.
The number of alleles in the ABO and Rh blood group systems, and the low antigenicity of all but the D antigen in the Rh system, make it relatively easy to supply blood in virtually unlimited quantities to patients requiring hemotherapy.
VEAs act on tumors to increase the concentration of conventional c hemotherapy in the tumor site while VTA's attach to tumor blood vessels creating a blood clot which kills the tumor by eliminating its oxygen and nutrient supply.
As for specialized care, seven new integrated health care centers will be built, and the existing network of hemotherapy the use of blood or blood derivatives will be boosted so as to improve emergency care.
3rd National Congress and Fifth Latin American Meeting on Hematology, Immunology and Hemotherapy, April 22-25, 1997, Havana, Cuba.